Breaking News
Get 55% Off 0
🍎 🍕 Less apples, more pizza 🤔 Have you seen Buffett’s portfolio recently?
Explore for Free
Close

SPDR® S&P Biotech ETF (XBI)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
94.30 +0.29    +0.31%
15:59:59 - Closed. Currency in USD
After Hours
94.22
-0.08
-0.08%
18:01:57 - Real-time Data
Type:  ETF
Market:  United States
Issuer:  SPDR
Asset Class:  Equity
  • Volume: 11,613,775
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 92.74 - 95.44
SPDR S&P Biotech 94.30 +0.29 +0.31%

XBI Recent Sentiments

 
Information on users’ sentiments for the SPDR S&P Biotech ETF, which are displayed both on charts of different periods of time and on a detailed table.
BearishBullish
Start Date Username Call Open Rate End Date Chg. %
Nov 19, 2024 Andrea Cicinelli   92.81 +1.61%
Nov 19, 2024 דוד דניאל   93.01 +1.39%
Nov 18, 2024 Siranush Khachatryan   92.14 +2.34%
Nov 15, 2024 איב שטרית   92.07 +2.42%
Nov 13, 2024 Kyle Dosher   101.13 -6.75%
Nov 13, 2024 Jose Carrasco   101.61 Nov 18, 2024 @ 92.42 -9.04%
Nov 13, 2024 alon subara   100.68 Nov 18, 2024 @ 92.42 -8.20%
Nov 12, 2024 אילי צוויג   103.02 Nov 18, 2024 @ 92.42 -10.29%
Nov 11, 2024 Porus Satwe   105.11 -10.28%
Nov 08, 2024 Airmany   103.02 Nov 11, 2024 @ 104.99 +1.91%
Nov 06, 2024 arman aateef   101.55 -7.14%
Nov 05, 2024 Yimei Sun   99.49 -5.22%
Nov 05, 2024 דניאל עובדיה   99.22 Nov 11, 2024 @ 104.99 +5.82%
Oct 31, 2024 HAMZA FAIQ   97.28 -3.06%
Oct 24, 2024 대준 배   97.81 Nov 15, 2024 @ 92.11 -5.83%
Oct 17, 2024 דוד דניאל   99.51 Nov 08, 2024 @ 103.98 +4.49%
Oct 14, 2024 محمد الفضلي   98.57 Nov 08, 2024 @ 103.98 -5.49%
Oct 07, 2024 César Lobo   95.98 Oct 14, 2024 @ 98.73 -2.87%
Oct 01, 2024 VASILIS RIGAS   98.72 Oct 07, 2024 @ 96.69 +2.06%
Sep 30, 2024 narcissur leavelove   98.10 Oct 07, 2024 @ 96.69 +1.44%
Sep 24, 2024 Jason Wang   98.05 Oct 18, 2024 @ 99.83 +1.82%
Sep 20, 2024 César Lobo   101.36 Sep 23, 2024 @ 100.31 +1.04%
Sep 19, 2024 pierre Chagny   103.24 Sep 23, 2024 @ 100.31 -2.84%
Sep 18, 2024 דוד דניאל   102.43 Oct 11, 2024 @ 98.68 -3.66%
Sep 16, 2024 Дмитрий Самоил   101.32 Sep 23, 2024 @ 101.20 -0.12%
Sep 16, 2024 nissan cohen   101.01 Oct 11, 2024 @ 98.68 -2.31%
Sep 06, 2024 César Lobo   96.28 Sep 09, 2024 @ 98.30 -2.10%
Aug 27, 2024 César Lobo   101.11 Sep 02, 2024 @ 101.26 -0.15%
Aug 27, 2024 محمد الفضلي   100.37 Sep 20, 2024 @ 101.58 +1.21%
Aug 27, 2024 Дмитрий Самоил   101.50 Sep 02, 2024 @ 101.26 +0.24%
Aug 23, 2024 יניב קרעי   101.69 Sep 13, 2024 @ 101.21 -0.47%
Aug 05, 2024 cruise bon   96.44 Aug 05, 2024 @ 93.83 -2.71%
Jul 26, 2024 Patrick Nugent   101.70 Aug 16, 2024 @ 97.75 -3.88%
Jul 26, 2024 용균 안   102.41 Jul 26, 2024 @ 102.41 0.00%
Jul 26, 2024 www tw   101.18 Jul 29, 2024 @ 100.23 -0.94%
Jul 22, 2024 محمد الفضلي   98.53 Aug 16, 2024 @ 97.75 +0.79%
Jul 16, 2024 Victor Korobkov   101.69 Jul 22, 2024 @ 97.69 -3.93%
Jul 16, 2024 محمد الفضلي   101.34 Jul 22, 2024 @ 98.09 +3.21%
Jul 15, 2024 محمد الفضلي   100.08 Jul 15, 2024 @ 100.01 +0.07%
Jul 09, 2024 محمد الفضلي   93.36 Jul 09, 2024 @ 94.41 +1.12%
Jul 09, 2024 محمد الفضلي   93.39 Jul 09, 2024 @ 93.35 +0.04%
Jul 01, 2024 יניב קרעי   93.85 Jul 26, 2024 @ 101.53 +8.18%
Jun 13, 2024 César Lobo   94.08 Jun 17, 2024 @ 90.22 +4.10%
Jun 03, 2024 Victor Korobkov   90.91 Jun 10, 2024 @ 91.24 +0.36%
Jun 03, 2024 דוד דניאל   91.11 Jun 28, 2024 @ 92.71 +1.76%
May 16, 2024 伟昌 梁   91.69 Jun 07, 2024 @ 91.39 +0.33%
May 03, 2024 דוד דניאל   91.52 May 24, 2024 @ 88.83 -2.94%
Apr 23, 2024 Jon Car   85.51 May 17, 2024 @ 91.18 +6.63%
Apr 17, 2024 César Lobo   85.19 Apr 22, 2024 @ 83.07 +2.49%
Apr 17, 2024 Дмитрий Самоил   86.03 Apr 18, 2024 @ 84.28 +2.03%
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

XBI Comments

Write your thoughts about SPDR® S&P Biotech ETF
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Feb 24, 2024 8:27AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I just finished my first trade this morning so I have been getting massive feedback from this for about a year I have been cashing out everyday without having problems from the service you indeed a good person to work with all thanks to you and your family. is wasp 31612574318°°° 0101001001001010101010100010000000000000000000000000000000000000000000000000000000000000000000000000000000000000
Jim Gardner
Jim Gardner Oct 23, 2023 8:44AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Three Black Crows on the monthly chart
Bulls MakeMore
Bulls MakeMore Oct 23, 2023 8:44AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Bay-bee here I am I'm a man on the scene,... ;)
Paul Kalifa
Paul Kalifa Oct 05, 2023 2:11PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I need a help
Zack Fick
Zack Fick Sep 24, 2023 5:11AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
The mRNA spike priteun graphene oxide bioweapon did this.
Mount Kilamanjaro
Mount Kilamanjaro Oct 26, 2022 11:43AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
The squueeze
Mount Kilamanjaro
Mount Kilamanjaro Oct 10, 2022 11:03AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Garbage junk going below 75 next week
Jack Belforte
Jack Belforte Sep 28, 2022 6:22AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Biotech stocks may provide a fair place to invest as markets try to avoid more weakness in the short term.
Mount Kilamanjaro
Mount Kilamanjaro Sep 09, 2022 1:23PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
10% gain in 3 days this is manipulated lmao
Mount Kilamanjaro
Mount Kilamanjaro Sep 06, 2022 5:32PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Dropping below 80
Артур Миньковский
Артур Миньковский Aug 26, 2022 6:16PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Waiting for 80, and after go up.Wait for it…
Mount Kilamanjaro
Mount Kilamanjaro Aug 26, 2022 6:16PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Interest rate hike is crappy for smaller corps. Its going below 80
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email